Edit page titleMerit Medical declared CIRSE 2019 conference collection Merit plan and product demonstrations - Merit Medical
Edit meta descriptionThrough its collection Merit plan, the company will be CIRSE in 2019 during the meeting the various learning opportunities

Close the edit interface

Merit Medical declared CIRSE 2019 conference Merit planning and product demonstrations

Merit will reveal its first-rate education study plan and CIRSE four field practice course of the organization

Maastricht, ND - 7 years on XNUMX 2019 -bob综合app官网Merit Medical Systems, Inc. (nasdaq stock code: MMSI) is mainly used in cardiology leading manufacturer and marketer of proprietary disposable instruments, announced on July 11 solstice XNUMX day held in Barcelona, Spain European cardiovascular and interventional radiology (CIRSE) conference of education initiative, activity and product demonstrations.

Through its Ask For Merit plan, the company will be in CIRSE session sponsored a variety of learning opportunities, in addition, will also be a four in-depth discussions, the focus is on varicose veins, rf tumor ablation, vertebral body enhancement and embolism - to celebrate the 10th anniversary of PAE and EmboCube launch, let the participants in-depth understanding of some of the company's latest innovations.

"In Merit, we are very pay attention to education and collaboration, in order to help push forward the industry and provide patients with better treatment effect.This is why CIRSE conference provides a great opportunity for us, can not only show our company and products, also can invite participants at very high levels of practice found Merit - our people, products, programs and services.It is through these programs, we can share knowledge, experience and interaction, and apply this knowledge to our research and innovation, in order to continuously improve our products, "Merit, chairman and chief executive Fred p. Lampropoulos said.

Merit products will be CIRSE occupies a significant position in the practice course of the organization.The meeting will be held on varicose veins on August 9, (Sunday), tumor ablation (October XNUMX Monday), embolism, and vertebral body enhancement (Tuesday) on XNUMX XNUMX meetings - for more information on the time and place, please refer to the CIRSE overview meeting.

Specifically, geniculate artery embolization is a topical anesthesia within an hour or so of minimally invasive surgery, has become the key to the conservative treatment failure of patients with knee osteoarthritis treatments, and will be a Merit CIRSE exist the core focus of this year.
In addition, the participants will also have the opportunity to experience Merit on their booth Surfacer, ClariVein, EmboCube and Biopsy product demo:
- Surfacer ® is proprietary Inside - Out®System restore access and retention of options
- ClariVein ® OC is a kind of innovative devices, designed for weeks out in the vasculature injection physician designated agents, including no function used for patients with superficial vein reflux endovascular occlusion of the vein.
- EmboCube ™ is pre-installed on Medallion ® syringe evenly cut gelatin foam in the cube, which can realize the preparation of faster and accurate delivery
- CorVocet ™ core biopsy system aimed at cutting complete organization, provides large sample for pathological examination.

Education of clinical doctors is still a prominent Merit.During the CIRSE congress, Merit will be held in 58, Merit learning center of booth to meet with experts, this is a series of expert lectures.Limited space available, for more information and registration, please visit the merit.com/CIRSE2019 Merit or visit the booth.

Lecture plan include:

Time Saturday, 7 September 2019
11-11:30
Dr Richard Lindsay - use CirQ nephrostomy catheter removal of continuous solution

But passion - 15:00
Tiago Bilhim Dr, diabetic foot reascularization, challenge

Time 8 years on Sunday, September 2019
09:15-10:00
Professor Dr Gurkan Sengolge - don't turn left: use the Surfacer ® system restore the pathway of chronic occluded vein (demonstration and hands-on)

At 10:30-11:00
Dr Mark Little - knee artery embolization: evidence, anatomy and technique

30-12:15
Dr Giovanni Carlo Anselmetti - using STAR ™ tumor ablation system and StabiliT ® vertebral enhance system management of spinal metastases

13:00-13:30
Dr Paul Lohle - uterine fibroid embolization and uterine adenomyosis

PM - passion
Dr Richard Lindsay - use CirQ nephrostomy catheter removal of continuous solution

15:00 - soon
Dr Mark Little - knee artery embolization: evidence, anatomy and technique

16:00 - ticket
Attila, Dr Kovacs Sbob体育imwiftNINJA ® : challenges for selective vascular catheterization controlled micro catheter.Case studies and success stories

17:00-17:30pm
Professor Dr Gurkan Sengolge - Surfacer ® system is practical: hands-on practice

Nine years on Monday, September 2019
09:00-09:30
Dr Tomas Bures: ClariVein ® OC infusion catheter - our experience of more than 1000 cases

09:45-10:45
Dr Roger Barranco - Pons: a different nerve intervention methods: through radial artery.

At 12:00 -
Professor Marc Sapoval: ThinkPAE ™, the principle of the prostate gland artery embolization evidence and technology

13:00 - when
Professor Dr Gurkan Sengolge - don't walk to the left: use Surfacer ® system restore the pathway of chronic occluded vein (demo = 15 minutes + hands-on = 30 minutes)

PM - passion
Dr Tomas Bures: ClariVein ® OC infusion catheter - our experience of more than 1000 cases

Hold - 16:00
Dr Mark Little - knee artery embolization: evidence, anatomy and technique

16.30:17-15: XNUMX
Professor Bernhard Meyer - HepaSphere ™ microspheres and conventional imaging

Ten years on Tuesday, September 2019
11-11:30
Dr Mark Little - knee artery embolization: evidence, anatomy and technique

12:00-12:45
Dr Giovanni Carlo Anselmetti - using STAR ™ tumor ablation system and StabiliT ® vertebral enhance system management of spinal metastases

13:00-13:30
Dr Mark Little - knee artery embolization: evidence, anatomy and technique

On Merit
bob综合app官网Merit Medical Systems, Inc., was founded in 1987, committed to the development, manufacture and distribution for intervention, diagnosis and treatment of proprietary programs of disposable Medical devices, particularly in cardiology, radiology and oncology, intensive care and endoscopy.Merit, has more than 300 domestic and international sales team and support team, clinical hospital providing services for global customers.Merit with about 6300 employees worldwide, in southern Utah Jordan;Pierre LAN, Texas;Richmond, va.Malvern, Pennsylvania;Massachusetts rockland;SAN jose, California and neatly and huo o;Maastricht in the Netherlands and Finland los;In Paris, France;爱尔兰戈尔韦; 中国北京; 墨西哥蒂华纳; 巴西若因维尔; 加拿大安大略省万锦市; 澳大利亚墨尔本; 日本东京;英国雷丁; 南非约翰内斯堡; 和新加坡设有机构。

[email protected]
+44 (0) 7740 948 378">Media contact
Laura Cameron (Laura Cameron)
Pascale Communications, LLC
[email protection]
+ 44 (0) 7740 948 378

The trademark